SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-004013
Filing Date
2022-03-21
Accepted
2022-03-21 17:02:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20220321xdefa14a.htm DEFA14A 19586
2 GRAPHIC tmb-20220321xdefa14a002.jpg GRAPHIC 51082
3 GRAPHIC tmb-20220321xdefa14a001.jpg GRAPHIC 69305
  Complete submission text file 0001558370-22-004013.txt   186581
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35565 | Film No.: 22756281
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences